TVTX
Travere Therapeutics Inc
52.10$
+0.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4.6% | 3.2% | 2.1% | 2.1% | 2.3% | 2.8% | 4.2% | 2.8% | 2.8% | 3.7% | 2.6% | 2.2% | 3.4% | 15.0% | 2.9% | 3.1% | 2.3% | 4.1% | 3.5% | 3.0% | 2.3% | 3.3% | 4.4% | 3.8% | 25.9% | 3.1% | 9.0% | 4.5% | 3.5% | 36.4% | 3.6% | 22.9% | 2.6% | 3.4% | 5.7% | 1.3% | 1.0% | 2.0% | 21.0% | 1.3% | 5.6% | |
| 95.4% | 96.8% | 97.9% | 97.9% | 97.7% | 97.2% | 95.8% | 97.2% | 97.2% | 96.3% | 97.4% | 97.8% | 96.6% | 85.0% | 97.1% | 96.9% | 97.7% | 95.9% | 96.5% | 97.0% | 97.7% | 96.7% | 95.6% | 96.2% | 74.1% | 96.9% | 91.0% | 95.5% | 96.5% | 63.6% | 96.4% | 77.1% | 97.4% | 96.6% | 94.3% | 98.7% | 99.0% | 98.0% | 79.0% | 98.7% | 94.4% | |
| 54.3% | 53.8% | 62.0% | 50.2% | 48.6% | 46.4% | 64.1% | 83.4% | 79.7% | 73.1% | 84.5% | 84.9% | 74.9% | 77.3% | 63.3% | 63.6% | 63.3% | 75.3% | 101.1% | 94.9% | 71.0% | 108.6% | 116.8% | 110.2% | 203.5% | 107.8% | 105.1% | 206.5% | 163.3% | 130.4% | 277.0% | 100.4% | 82.2% | 83.0% | 57.4% | 43.1% | 31.5% | 44.6% | 44.9% | 35.5% | 38.4% | |
| 85.6% | 71.3% | 68.8% | 74.3% | 61.6% | 64.7% | 68.9% | 60.7% | 64.1% | 59.3% | 82.6% | 87.2% | 67.1% | 59.0% | 69.4% | 72.2% | 62.5% | 70.1% | 75.4% | 64.0% | 52.9% | 73.5% | 115.2% | 106.9% | 186.7% | 112.6% | 115.7% | 211.8% | 182.8% | 141.1% | 155.2% | 119.7% | 104.3% | 92.9% | 89.1% | 66.6% | 52.4% | 78.4% | 63.1% | 56.7% | 61.6% | |
| 139.9% | 125.1% | 130.8% | 124.5% | 110.2% | 111.1% | 133.0% | 144.1% | 143.8% | 132.4% | 167.1% | 172.0% | 140.4% | 125.5% | 128.7% | 144.6% | 135.7% | 328.5% | 196.8% | 161.6% | 144.2% | 179.1% | 213.3% | 217.0% | 368.3% | 216.6% | 231.9% | 418.4% | 346.1% | 247.4% | 432.9% | 201.0% | 186.7% | 177.8% | 146.5% | 109.7% | 83.9% | 123.0% | 108.0% | 96.4% | 101.2% | |
| -60.0% | -48.8% | -42.9% | -35.0% | -26.3% | -36.0% | -46.6% | -52.2% | -87.4% | -11.4% | -96.6% | -81.7% | -77.6% | -40.6% | -31.5% | -47.7% | -38.0% | -232.5% | -100.3% | -64.7% | -46.5% | -82.4% | -117.7% | -120.8% | -294.2% | -119.7% | -140.9% | -322.9% | -249.6% | -183.8% | -336.5% | -123.9% | -89.3% | -81.2% | -52.2% | -11.1% | 15.1% | -25.0% | -29.0% | 2.3% | -6.8% | |
| 0.9% | 1.2% | 0.4% | 1.7% | 1.6% | 0.8% | 0.9% | 2.6% | 6.2% | 11.6% | 12.3% | 10.8% | 10.2% | 9.8% | 10.2% | 9.6% | 9.3% | 9.3% | 11.2% | 8.9% | 7.2% | 8.9% | 5.2% | 5.5% | 10.1% | 5.2% | 5.0% | 8.8% | 7.6% | 6.3% | 6.8% | 5.2% | 4.4% | 3.8% | 3.5% | 2.5% | 1.7% | 1.8% | 1.8% | 1.3% | 1.6% | |
| -90.3% | -32.9% | -39.1% | -39.1% | -47.1% | -26.2% | -47.2% | -53.6% | -132.9% | -17.0% | -102.5% | -86.4% | -83.4% | -64.7% | -38.0% | -53.7% | -44.0% | -239.5% | -113.0% | -71.3% | -52.2% | -90.1% | -156.6% | -123.7% | -298.9% | -117.7% | -169.3% | -316.4% | -240.5% | -196.5% | -328.1% | -128.6% | -87.2% | -80.7% | -50.4% | -11.1% | 15.6% | -16.2% | -28.9% | -20.6% | -11.3% | |
| 19.1% | -9.9% | -6.1% | -5.0% | -3.0% | 15.6% | 0.6% | 0.4% | 1.0% | -24.7% | 1.0% | 0.2% | -1.2% | 0.1% | -39.7% | 0.1% | 0.0% | -0.9% | 0.7% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.5% | 0.1% | 0.1% | 0.2% | 0.0% | 0.2% | 0.5% | 0.2% | -0.1% | -0.1% | 0.0% | 0.0% | 0.0% | 0.7% | -0.1% | -0.1% | 0.1% | |
| -109.3% | -23.0% | -33.0% | -34.1% | -44.1% | -41.8% | -47.8% | -54.0% | -133.9% | -17.0% | -103.6% | -86.6% | -82.2% | -64.8% | 1.7% | -53.8% | -44.1% | -238.6% | -113.6% | -71.4% | -52.2% | -90.1% | -156.7% | -123.8% | -248.1% | -117.8% | -151.5% | -266.0% | 406.3% | -200.1% | -328.9% | -130.1% | -87.1% | -80.6% | -50.4% | -11.1% | 15.6% | 2.1% | -29.2% | -20.5% | -7.4% | |
| -76.5% | -20.5% | -25.1% | -25.2% | -35.5% | -14.6% | -35.0% | -41.9% | -114.9% | 5.7% | -77.9% | -64.8% | -61.1% | -43.6% | -16.0% | -32.0% | -22.1% | -217.1% | -88.9% | -50.3% | -33.5% | -70.7% | -136.8% | -103.2% | -266.9% | -95.9% | -147.5% | -273.6% | -202.0% | -163.9% | -297.5% | -104.3% | -64.9% | -60.7% | -31.2% | 3.6% | 26.8% | -0.5% | -7.2% | -16.9% | 1.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.